|
C20ORF194 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.604300E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.28129999999949E-05 |
| Normal-vs-Stage2 |
4.665200E-01 |
| Normal-vs-Stage3 |
1.295770E-01 |
| Normal-vs-Stage4 |
4.42070000000738E-05 |
| Stage1-vs-Stage2 |
1.609150E-01 |
| Stage1-vs-Stage3 |
6.855800E-01 |
| Stage1-vs-Stage4 |
2.527000E-01 |
| Stage2-vs-Stage3 |
5.335200E-01 |
| Stage2-vs-Stage4 |
6.765800E-02 |
| Stage3-vs-Stage4 |
1.556630E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.962500E-04 |
| Normal-vs-AfricanAmerican |
2.082300E-03 |
| Normal-vs-Asian |
7.138600E-03 |
| Caucasian-vs-AfricanAmerican |
7.416600E-01 |
| Caucasian-vs-Asian |
6.088400E-01 |
| AfricanAmerican-vs-Asian |
6.385400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.68036000000038E-05 |
| Normal-vs-Female |
3.723000E-01 |
| Male-vs-Female |
3.061700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.279700E-03 |
| Normal-vs-Extreme_Weight |
4.68470000003496E-06 |
| Normal-vs-Obese |
1.729780E-01 |
| Normal-vs-Extreme_Obese |
1.798350E-03 |
| Normal_Weight-vs-Extreme_Weight |
3.617200E-01 |
| Normal_Weight-vs-Obese |
2.446200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.399600E-01 |
| Extreme_Weight-vs-Obese |
1.728360E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.680000E-01 |
| Obese-vs-Extreme_Obese |
2.567800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.433600E-01 |
| Normal-vs-Age(41-60Yrs) |
8.070200E-02 |
| Normal-vs-Age(61-80Yrs) |
2.19629999997917E-06 |
| Normal-vs-Age(81-100Yrs) |
5.796000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.567200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.784250E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.630560E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.454470E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.539500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.418600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.016400E-04 |
| Normal-VS-Type2 PRCC |
1.152080E-04 |
| Normal-VS-KIRP CIMP |
6.175700E-02 |
| Normal-VS-Unclassified PRCC |
8.077000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.253160E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.636400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.434640E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.113000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.847970E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.352400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.370100E-04 |
| Normal-vs-N1 |
9.461900E-03 |
| Normal-vs-N2 |
2.004900E-03 |
| N0-vs-N1 |
6.933800E-01 |
| N0-vs-N2 |
5.477200E-01 |
| N1-vs-N2 |
3.763200E-01 |
|
|
